Register for Zoom link
Or attend in person at:
ZSFGH, Pride Hall, ZRAB Conf Room 1940
Light refreshments will be served
Learning objectives:
- Describe the pharmacological properties of buprenorphine that inform clinical decision-making for induction strategies, including its partial agonist activity, high receptor affinity, and formulation-specific pharmacokinetics.
- Compare evidence-based buprenorphine induction approaches for outpatient settings, including large dose, low-dose overlap, and direct-to-inject approaches, and identify appropriate patient selection criteria for each method.
Evaluate the clinical applications, benefits, and limitations of direct-to-inject buprenorphine initiation, including patient selection considerations and implementation challenges for first- and second-generation long-acting injectable products.
Agenda
12:00 - 12:10 p.m. Introduction and overview Dr. Leslie Suen 12:10 - 12:30 p.m. Bup pharmacology Dr. Damian Peterson 12:30 - 1:00 p.m. Starting bup in the outpatient setting: a menu of options Dr. Leslie Suen 1:00 - 1:30 p.m. Direct-to-inject: Promises and Pitfalls Dr. Sarah Rosenwohl-Mack 1:30 - 2:00 p.m. Q&A
